Clinical Trials Directory

Trials / Unknown

UnknownNCT02301650

The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children

The Effect of Anti-viral Drugs Used in Late Pregnancy in Mothers With Hepatitis B Virus Infection on Long-term Development of Children

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Beijing Ditan Hospital · Academic / Other
Sex
All
Age
1 Year – 3 Years
Healthy volunteers
Not accepted

Summary

Mother to child transmission(MTCT) is the main route of hepatitis B virus(HBV) transmission.High HBV DNA level of pregnant women is the main risk factor of MTCT. Many literatures demonstrate that using nucleoside (acid) analogs in late pregnancy can significantly reduce HBV DNA level and effectively blocking MTCT. Therefore, treatment guidelines of hepatitis B in Europe and the Asia Pacific region clearly pointed out: Nucleoside (acid) analogs can be used in pregnant women after 28 weeks of gestation for blocking MTCT in mothers with high HBV DNA level. At present, the drugs used in late pregnancy including lamivudine (LAM) ,telbivudine(LdT) and tenofovir(TDF). The safety of nucleoside (acid) analogues used in late pregnancy on children is not clear.In most of the related researches,the observation termination was 7-12 months after birth, and most were concentrated on the blocking effect of MTCT.The long-term impact of Nucleoside (acid) analogues on children's development has not been reported in the literatures. The aim of this study is to make clear of the effect of nucleoside (acid) analogues used in late pregnancy on long-term impact of children's development. The one year old children born in Beijing Ditan hospital and whose mothers had taken LAM,LdT or TDF during late pregnancy will be enrolled as study group, and eligible children whose mothers untreated will be enrolled as control group. The children's height, weight, nutritional status, developmental quotient and immune response to hepatitis B vaccine etc will be evaluated at baseline and at 3 years old. By comparing the children's development in different groups as well as in self-control of different ages, we will discuss the effect of Nucleoside (acid) analogues on children's long-term development.

Conditions

Interventions

TypeNameDescription
DRUGLamivudinemothers use Lamivudine in late pregnancy
DRUGTelbivudinemothers use Telbivudine in late pregnancy
DRUGTenofovirmothers use Tenofovir in late pregnancy

Timeline

Start date
2014-10-01
Primary completion
2017-10-01
Completion
2017-12-01
First posted
2014-11-26
Last updated
2014-11-26

Source: ClinicalTrials.gov record NCT02301650. Inclusion in this directory is not an endorsement.